Clinical Research Directory

Inclusion Criteria: * Provision of signed and dated electronic informed consent form * Stated willingness to comply with all study procedures and availability for the duration of the study * Age 18 or older. * Documented diagnosis of chemotherapy-induced peripheral neuropathy meeting the following criteria: 1) onset associated with timing of neurotoxic chemotherapy and 2) symptomatic reports of peripheral neuropathy. * Access to smartphone and internet for participating in a technology-based intervention * Upcoming in-person appointment in the Main Hospital Pain Management Clinic 4-6 weeks from the consent date. * English-speaking * Pain or bothersome symptoms present most days of the week at an average of ≥4/10 on the Numeric Rating Scale for the past 3 months * No longer receiving cancer treatment or has been on stable maintenance treatment for the past 3 months. * Resides in the Houston Metroplex * A score ≤7 on the validated Six Item Cognitive Impairment Test (6CIT) for unimpaired cognition Exclusion Criteria: * Provision of signed and dated electronic informed consent form * Stated willingness to comply with all study procedures and availability for the duration of the study * Age 18 or older. * Documented diagnosis of chemotherapy-induced peripheral neuropathy meeting the following criteria: 1) onset associated with timing of neurotoxic chemotherapy and 2) symptomatic reports of peripheral neuropathy. * Access to smartphone and internet for participating in a technology-based intervention * Upcoming in-person appointment in the Main Hospital Pain Management Clinic 4-6 weeks from the consent date. * English-speaking * Pain or bothersome symptoms present most days of the week at an average of ≥4/10 on the Numeric Rating Scale for the past 3 months * No longer receiving cancer treatment or has been on stable maintenance treatment for the past 3 months. * Resides in the Houston Metroplex * A score ≤7 on the validated Six Item Cognitive Impairment Test (6CIT) for unimpaired cognition